For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Alarm bells sound as prospect of greater activity in medical competence arena raises indemnity shortcomings
+Print Archive
Etcetera
Alarm bells sound as prospect of greater activity in medical competence arena raises indemnity shortcomings
Wednesday 17 June 2020, 04:15 AM

In Australia, where the courts determine fault, the medicolegal industry is in disarray following the collapse of the largest medical defence organisation in 2002
LETTER
Ross Blair, retired thoracic and vascular surgeon, is chair of medical defence company Medicus. He previously spent seven years on the panel of the Medical Protection Society. He is worried about vulnerability he sees in the medicolegal environment in New Zealand
From being relatively stable and equitable, there are worrying signs that the New Zealand medicolegal climate is heating up.
New Zealand doctors s
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.